| Summary: | Botulinum toxin is a local drug use which worldwide has proven its effective in the treatment of focal dystonia in adults over oral medications and even surgery, provoking the opening of an outpatient clinic to treat patients without income at "Arnaldo Milian Castro" University Provincial Hospital in 2003. A descriptive, cross-sectional study was performed in patients with focal dystonia in the period of January 2004 to December 2013. Study population consisted of patients with focal dystonia attended in the botulinum toxin clinical office (171) and agreed with the sample. The most frequent age of presentation of focal dystonia was 40-60 years, females and white skin color predominated and dystonia more often treated was the blepharospasm. A month of having applied the treatment with botulinum toxin, satisfactory response predominated in the majority of dystonias, except in laryngeal dystonia by abduction. 86.5% of patients, after applying medication, they incorporated to the social and labor life.
|
|---|